Methods of treating or preventing respiratory tract infection comprising administering cholecalciferol

Details for Australian Patent Application No. 2008296310 (hide)

Owner The Procter & Gamble Company

Inventors Rennie, Paul John; Clymer, Jeffrey Warren

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008296310

PCT Pub. Number WO2009/032887

Priority 60/967,412 04.09.07 US

Filing date 4 September 2008

Wipo publication date 12 March 2009

International Classifications

A61K 31/592 (2006.01)

A61K 31/593 (2006.01)

A61K 35/74 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 36/82 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

1 April 2010 PCT application entered the National Phase

  PCT publication WO2009/032887 Priority application(s): WO2009/032887

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008296311-Method for providing energy, relieving stress and mood enhancing benefits comprising administering a composition comprising cholecalciferol and a tea extract

2008296309-Fiber optic enclosure with tear-away spool